Which county got biggest share of 2024 Tirlán milk payments?
According to the co-op milk payments last year were a 'huge driver of the rural economy' and helped to support 19,200 jobs.
Tirlán today published its 2024 annual report which revealed milk payments by county and topping the poll were dairy farmers in Co. Kilkenny who received the lion's share of payments totaling €263 million.
Dairy farmers in Co. Waterford were second on the list of Tirlán' s league table of milk payments as they received payments amounting to €237 million last year while farmers in Co. Tipperary were third on the list with payments of €206 million.
Meanwhile dairy farmers in Co. Monaghan were at the bottom of the 2024 Tirlán milk payments table as they received a total of€4 million.
Source: Tirlán
The latest annual report also highlights the volume of milk supplies collected by Tirlán in Northern Ireland during 2024, according to its latest annual report milk payment to farmers in Northern Ireland totaled £61 million last year.
Tirlán milk suppliers
In its latest annual report Tirlán states it is 'Ireland's largest milk processor with 3.028 billion milk pool' and highlighted that last year it returned an average milk price of 52c/L.
This compares to the average price paid for milk in 2023 by Tirlan to its milk suppliers which was 44c/L, that had been significantly down on the average price in 2022 of 63c/L.
Although the co-op said that milk supply 'made a strong recovery in the later months of 2024 to finish the year' overall it was approximately '1% back on 2024 volumes'.
In 2023 the co-op's milk pool decreased by 3% to 3.1 billion litres.
Tirlán's chief executive, Seán Molloy, today warned that 2025 'is vital for the agricultural sector and rural economy with a decision due on Ireland's retention of the nitrates serogation'.
'We need certainty for our farmers and the retention of a fit-for-purpose derogation.
'In Ireland and in Brussels, Tirlán has continued to highlight the positive actions being taken by our members to improve water quality,' Molloy said.
He also highlighted that the co-op is 'working to assist our farmers to increase milk solids
production in a sustainable manner to drive farm income through our new milk solids growth programme. The CEO outlined that this 'will be a significant focus for the business in 2025.
Molloy said: 'As we look to the future, generational renewal is key for our co-op.
'We believe we have a strong benefits package and supports to offer new milk suppliers, with over 50 new entrants and new suppliers to Tirlán joining in 2024.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Independent
13 hours ago
- Irish Independent
Pharma companies warned Government over competitiveness before Trump's tariff war began
Multinationals criticised the impact of EU rules on how they do business Major pharmaceutical companies raised concerns about Ireland's competitiveness, ahead of Donald Trump's opening shots in early April which began the tariff war with the EU. Correspondence released under the Freedom of Information Act to the Sunday Independent show that companies called on the Government to address supply chain issues and ensure there was a diverse and skilled workforce here. They also criticised the impact of EU regulations on how they do business. The warnings from Eli Lilly and Johnson & Johnson came before Mr Trump heightened uncertainty in the sector by announcing sweeping global trade tariffs, and underlined the need for Ireland to react if it is to retain its significant foreign direct investment from the pharma sector. Multinational pharmaceutical companies play a significant role in Ireland's economy. IDA Ireland data shows more than 90 pharmaceutical companies are based here and provide in the region of 45,000 jobs. They also pay billions in corporation tax. US-headquartered Eli Lilly, which employs 3,500 people in Limerick, Cork and on a nationwide commercial team, met with Department of Enterprise officials in February and outlined their concerns around the future of the EU-US trading relationship. Meanwhile, Johnson & Johnson told Enterprise Minister Peter Burke that policy enhancements for business, health and housing 'should be considered in a co-ordinated manner that reflects national strategic priorities'. Trump has threatened future tariffs of between 150pc and 250p on pharma Notes from the Eli Lilly meeting show it told Department of Enterprise and IDA Ireland officials that it wants to see 'greater intensity from Ireland at EU level, specifically around the EU pharmaceutical legislation.' New EU pharma rules, which may be adopted by the end of this year, are designed to address issues around the availability of medicines, how they are produced, and aim to improve competitiveness in the sector. But some businesses raised concerns about the protections for clinical data before it is made available to the manufacturers of cheaper generic versions of drugs. Existing rules allow pharma companies to keep clinical data for eight years. Reforms would reduce this period to six years, although extensions may apply in some scenarios. Officials here said they recognised the need to strike a balance between access to affordable medicines and incentivising innovation. Notes from the Eli Lilly meeting show officials in the Department of Enterprise acknowledged EU-US trade concerns in the pharma sector, saying 'predictability is key for business' and that European engagement would be 'bolstered by expertise from industry'. The company 'also highlighted the importance of de-risking supply chains, ensuring there is a diverse skillset in Irish operations' and said that it 'would like to see more regulation co-operation between the US and EU, especially with the US Food and Drug Administration,' meeting notes stated. A letter sent to Mr Burke by Michaela Hagenhofer, Johnson & Johnson's general manager of commercial operations in Ireland, raised concerns about the European Commission proposing 'to weaken intellectual property incentives for pharmaceuticals… from eight years to six'. The letter stated: 'At European level, it is important that Ireland secures and strengthens its reputation as a life sciences hub by advocating for a competitive business environment. In recent decades, Europe's share of pharmaceutical investment has significantly declined.' A Department of Enterprise spokesman said it supports protecting intellectual property 'and will continue to make the case for this at EU level'. The EU and US last month agreed a 15pc tariff rate would apply on most European goods imported to America. Pharmaceutical goods are not currently the subject of this tariff, but the US is examining its drug supply chains, and levies could be imposed once that analysis concludes. European Commission president Ursula von der Leyen has said any future pharma tariffs would be capped at 15pc. Trump indicated this cap may only be maintained for 'one year, one-and-a-half years maximum' and threatened future rates of between 150pc and 250pc unless pharma companies return production to the US. 'The department welcomes an agreement that will provide much needed certainty to businesses which operate in Ireland and will continue to engage with the Department of Foreign Affairs and the European Commission,' a Department of Enterprise spokesman said. 'The Department has favoured a zero-for-zero arrangement and will continue to argue against any tariffs which may interfere with the closely integrated nature of the Irish and US pharmaceutical sectors.'
Agriland
a day ago
- Agriland
Dairy breeding elite set for Cavan as Baileys Champion Cow returns
Some of the best Holstein Friesian genetics in Ireland will be on show at this year's Diageo Baileys Champion Dairy Cow Competition, taking place at the Virginia Show on Wednesday, August 20. According to competition co-ordinator Patrick Gaynor, it is not just the €13,000 prize fund that has attracted a strong response from breeders across Ireland this year. Gaynor mentioned that 28 cows are entered, including a record eight coming from four Northern Irish counties - Antrim, Armagh, Derry, and Down - with other exhibitors travelling from as far away as counties Cork, Kerry, Limerick and Tipperary. He also paid tribute to the support of both the Irish Holstein Friesian Association and Holstein Northern Ireland (NI), crediting the warm welcome and the prestige of the 'Baileys Cow' title as the main draw for exhibitors. 'The welcome competitors receive from the organisers and sponsors as well as the prestige of even taking part in a competition as well known as 'the Baileys' is I believe what makes it special.' Now in its fifth decade, the competition continues to be one of the most sought-after titles in the pedigree dairy community, backed by one of the longest-running sponsorship partnerships in Irish agriculture – between Diageo, owner of Baileys Irish Cream, and its cream supplier Tirlán. The cream for Baileys is produced down the road from the showgrounds at Tirlán's Virginia site, making the event a showcase for the global brand's Irish provenance. Judging duties this year will fall to Italian breeder Giuseppe Beltramino from northern Italy. MC duties will once again be handled by Michael Taffe. Proceedings get underway at 3.00pm, preceded by a parade of the Holstein Friesians entering the main ring. A special VIP guest will join Diageo Ireland's corporate relations director Shane Kelly and Tirlán chairperson John Murphy to present the top prize and the Virginia Milk Products Cup trophy.
RTÉ News
5 days ago
- RTÉ News
Dawn Meats agrees deal with New Zealand's Alliance Group
Dawn Meats has announced a deal to acquire a majority stake in New Zealand meat producer Alliance Group. The Waterford-headquartered firm will take a 65% stake in the business as part of a €127.7m investment. Alliance is New Zealand's largest processor and exporter of lamb, and operates six processing plants in the country. It is owned by about 4,300 shareholders, The proposed partnership is still subject to shareholder approval as well as New Zealand High Court and regulatory approvals. Niall Browne, chief executive of Dawn Meats, said the company was pleased to have been selected as the preferred long-term strategic partner of the Alliance Group. "As the largest retail packer of New Zealand lamb in the UK, Dawn Meats is familiar with the high standards of the country's grass-fed meat industry and its produce. We have worked closely with Alliance for many years in this regard, and we greatly admire the exceptional quality of their world class grass-fed lamb, beef and venison," Mr Browne said. He said that Dawn Meats has a successful operating and investment track record in Ireland, the UK and in the EU. "Having the ability to grow in partnership with some of New Zealand's leading farmers and create a year-round supply for our customers between the Northern and Southern Hemispheres is an opportunity we are deeply committed to and take very seriously," he added. Mark Wynne, Alliance Group Chair, said the announcement comes after a two-year process to reset and recapitalise Alliance. "Alliance was built by farmers for farmers and has a proud cooperative legacy. The process we have undertaken on behalf of our farmer-shareholders to meet our banks' requirements means we are now a much fitter and stronger business. However, we need this investment to provide certainty and confidence and ultimately unlock more value for our farmers," he said. "We are at a critical point where the business needs to evolve, but our commitment to farmers remains the same, and we believe Dawn Meats' offer stands to secure and strengthen Alliance's future," he stated. "With Dawn Meats' balance sheet power, strength in beef and market access across the UK and Europe, and Alliance's strength in lamb and market access across Asia, China and North America, there are significant commercial and operational synergies at stake - with potential for our shareholders to see the value of their residual 35% stake grow over the long term," he added.
